Cargando…

Anti-Vascular Endothelial Growth Factor C Antibodies Efficiently Inhibit the Growth of Experimental Clear Cell Renal Cell Carcinomas

Despite improvement during the last ten years in the longevity of patients with metastatic clear cell renal cell carcinoma (mccRCC) the disease remains incurable. Hence, new therapeutic strategies are urgently needed. Relapse following anti-angiogenic treatment depends on the over-expression of vasc...

Descripción completa

Detalles Bibliográficos
Autores principales:	Dumond, Aurore, Montemagno, Christopher, Vial, Valérie, Grépin, Renaud, Pagès, Gilles
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8157203/ https://www.ncbi.nlm.nih.gov/pubmed/34067671 http://dx.doi.org/10.3390/cells10051222

Ejemplares similares

Neuropilin 1 and Neuropilin 2 gene invalidation or pharmacological inhibition reveals their relevance for the treatment of metastatic renal cell carcinoma
por: Dumond, Aurore, et al.
Publicado: (2021)

The combination of bevacizumab/Avastin and erlotinib/Tarceva is relevant for the treatment of metastatic renal cell carcinoma: the role of a synonymous mutation of the EGFR receptor
por: Grépin, Renaud, et al.
Publicado: (2020)

Neuropilins, as Relevant Oncology Target: Their Role in the Tumoral Microenvironment
por: Dumond, Aurore, et al.
Publicado: (2020)

Molecular Mechanisms of Resistance to Tumour Anti-Angiogenic Strategies
por: Grépin, Renaud, et al.
Publicado: (2010)

Antiangiogenic Compound Axitinib Demonstrates Low Toxicity and Antitumoral Effects against Medulloblastoma
por: Pagnuzzi-Boncompagni, Marina, et al.
Publicado: (2021)

The ELR(+)CXCL chemokines and their receptors CXCR1/CXCR2: A signaling axis and new target for the treatment of renal cell carcinoma
por: Giuliano, Sandy, et al.
Publicado: (2014)

Up-Regulation of Intestinal Vascular Endothelial Growth Factor by Afa/Dr Diffusely Adhering Escherichia coli
por: Cane, Gaëlle, et al.
Publicado: (2007)

Prognostic Value of Vascular Endothelial Growth Factor A in the Prediction of the Tumor Aggressiveness in Clear Cell Renal Cell Carcinoma
por: Veselaj, Fahredin, et al.
Publicado: (2017)

In vivo monitoring of the therapeutic efficacy of a CXCR1/2 inhibitor with 18F-FDG PET/CT imaging in experimental head and neck carcinoma: A feasibility study
por: Montemagno, Christopher, et al.
Publicado: (2021)

Role of hypoxia and vascular endothelial growth factors in lymphangiogenesis
por: Morfoisse, Florent, et al.
Publicado: (2014)

Role of hypoxia and vascular endothelial growth factors in lymphangiogenesis
por: Morfoisse, Florent, et al.
Publicado: (2015)

Effect of Anti-vascular Endothelial Growth Factor Antibody on the Survival of Cultured Retinal Ganglion Cells
por: Lee, Ji Min, et al.
Publicado: (2017)

Effects of anti-vascular endothelial growth factor monoclonal antibody (bevacizumab) on lens epithelial cells
por: Jun, Jong Hwa, et al.
Publicado: (2016)

Inhibited growth of colon cancer carcinomatosis by antibodies to vascular endothelial and epidermal growth factor receptors
por: Shaheen, R M, et al.
Publicado: (2001)

Expression of vascular endothelial growth factor-C and vascular endothelial growth factor receptor-3 in esophageal squamous cell carcinoma
por: OMOTO, ITARU, et al.
Publicado: (2014)

Anti-vascular endothelial growth factor antibody attenuates inflammation and decreases mortality in an experimental model of severe sepsis
por: Jeong, Su Jin, et al.
Publicado: (2013)

The Relevance of Testing the Efficacy of Anti-Angiogenesis Treatments on Cells Derived from Primary Tumors: A New Method for the Personalized Treatment of Renal Cell Carcinoma
por: Grépin, Renaud, et al.
Publicado: (2014)

Bevacizumab, an anti-vascular endothelial growth factor antibody, inhibits osteoarthritis
por: Nagai, Toshihiro, et al.
Publicado: (2014)

Vascular endothelial growth factors and vascular permeability
por: Bates, David O.
Publicado: (2010)

Resistance to Anti-angiogenic Therapies: A Mechanism Depending on the Time of Exposure to the Drugs
por: Montemagno, Christopher, et al.
Publicado: (2020)

Metastatic Heterogeneity of Breast Cancer: Companion and Theranostic Approach in Nuclear Medicine
por: Montemagno, Christopher, et al.
Publicado: (2020)

Associations between Tumor Vascularity, Vascular Endothelial Growth Factor Expression and PET/MRI Radiomic Signatures in Primary Clear-Cell–Renal-Cell-Carcinoma: Proof-of-Concept Study
por: Yin, Qingbo, et al.
Publicado: (2017)

Vascular endothelial growth factor‐D modulates oxidant–antioxidant balance of human vascular endothelial cells
por: Papiewska‐Pająk, Izabela, et al.
Publicado: (2016)

Vascular endothelial growth factor, platelet-derived endothelial cell growth factor and angiogenesis in non-small-cell lung cancer
por: O'Byrne, K J, et al.
Publicado: (2000)

HUMAN VASCULAR ENDOTHELIAL CELLS IN CULTURE : Growth and DNA Synthesis
por: Gimbrone, Michael A., et al.
Publicado: (1974)

Dual Pathways to Tubular Morphogenesis of Vascular Endothelial Cells by Human Glioma Cells: Vascular Endothelial Growth Factor/Basic Fibroblast Growth Factor and Interleukin‐8
por: Wakabayashi, Yukihiro, et al.
Publicado: (1995)

CXCL7 is a predictive marker of sunitinib efficacy in clear cell renal cell carcinomas
por: Dufies, Maeva, et al.
Publicado: (2017)

A group of novel VEGF splice variants as alternative therapeutic targets in renal cell carcinoma
por: Montemagno, Christopher, et al.
Publicado: (2023)

Carbonic Anhydrase 9 Expression Increases with Vascular Endothelial Growth Factor–Targeted Therapy and Is Predictive of Outcome in Metastatic Clear Cell Renal Cancer
por: Stewart, Grant D., et al.
Publicado: (2014)

Acetylbritannilactone Modulates Vascular Endothelial Growth Factor Signaling and Regulates Angiogenesis in Endothelial Cells
por: Zhao, Jingshan, et al.
Publicado: (2016)

Capture of endothelial cells under flow using immobilized vascular endothelial growth factor
por: Smith, Randall J., et al.
Publicado: (2015)

Vascular endothelial growth factor levels and rheumatic diseases of the elderly
por: Smets, Perrine, et al.
Publicado: (2016)

Hypoxia inducible factor-1α correlates with vascular endothelial growth factor A and C indicating worse prognosis in clear cell renal cell carcinoma
por: Đorđević, Gordana, et al.
Publicado: (2009)

The effects of ovarian cancer cell-derived exosomes on vascular endothelial growth factor expression in endothelial cells
por: Ghorbanian, Mohammad, et al.
Publicado: (2019)

Cheiradone: a vascular endothelial cell growth factor receptor antagonist
por: Hussain, Sajjad, et al.
Publicado: (2008)

Deletion of Vascular Endothelial Growth Factor in myeloid cells accelerates tumorigenesis
por: Stockmann, Christian, et al.
Publicado: (2008)

Expression of vascular endothelial growth factor in oral squamous cell carcinoma
por: Kim, Seok-Kon, et al.
Publicado: (2015)

The Effect of Stem Cells and Vascular Endothelial Growth Factor on Cancer Angiogenesis
por: Moradi-Gharibvand, Nahid, et al.
Publicado: (2023)

Expression of Vascular Endothelial Growth Factor on Chondrocytes Increases with Osteoarthritis - An Animal Experimental Investigation
por: Tibesku, C.O, et al.
Publicado: (2011)

The Impact of Experimental Preconditioning Using Vascular Endothelial Growth Factor in Stroke and Subarachnoid Hemorrhage
por: Eicker, Sven Oliver, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_ploe5dab33ptivqnsqs2lgt7qa